At the time of writing, Jade Biosciences Inc [JBIO] stock is trading at $17.03, up 2.84%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The JBIO shares have gain 13.68% over the last week, with a monthly amount glided 36.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jade Biosciences Inc [NASDAQ: JBIO] stock has seen the most recent analyst activity on October 09, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $28. Previously, Jefferies started tracking the stock with Buy rating on July 14, 2025, and set its price target to $16. On June 16, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $14 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $17 on May 07, 2025. Stifel initiated its recommendation with a Buy and recommended $19 as its price target on May 05, 2025. TD Cowen started tracking with a Buy rating for this stock on May 02, 2025, and assigned it a price target of $10. In a note dated June 18, 2024, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $35 to $2.
For the past year, the stock price of Jade Biosciences Inc fluctuated between $6.57 and $16.77. Currently, Wall Street analysts expect the stock to reach $28 within the next 12 months. Jade Biosciences Inc [NASDAQ: JBIO] shares were valued at $17.03 at the most recent close of the market. An investor can expect a potential return of 64.42% based on the average JBIO price forecast.
Analyzing the JBIO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.49 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.48 points at the first support level, and at 15.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.64, and for the 2nd resistance point, it is at 18.26.
Ratios To Look Out For
It is important to note that Jade Biosciences Inc [NASDAQ:JBIO] has a current ratio of 9.01. Further, the Quick Ratio stands at 9.01, while the Cash Ratio is 2.24.
Transactions by insiders
Recent insider trading involved Atlas Venture Fund XII, L.P., Shareholder, that happened on Jun 25 ’25 when 28977.0 shares were purchased. Shareholder, Atlas Venture Associates XII, completed a deal on Jun 25 ’25 to buy 235.0 shares. Meanwhile, Shareholder Atlas Venture Fund XII, L.P. bought 16132.0 shares on Jun 24 ’25.
